Alpha 2.0
Login Register
» Authors » P Januszewicz

P Januszewicz

Explore the profile of P Januszewicz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 41
Citations 244
Followers 0
Related Specialties
General Medicine
Pediatrics
Physiology
Top 10 Co-Authors
T WYSZYNSKA
J Gutkowska
M Cantin
J Genest
G Thibault
E Cichocka
R Garcia
A Wieteska-Klimczak
J Zawadzki
H Ignatowska-Switalska
Published In
Pediatr Pol
Pol Tyg Lek
Biochem Biophys Res Commun
Prostaglandins Med
Acta Physiol Pol
Affiliations
Soon will be listed here.
Recent Articles
1.
A nursing shortage - a prospect of global and local policies
Marc M, Bartosiewicz A, Burzynska J, Chmiel Z, Januszewicz P
Int Nurs Rev . 2018 Jul; 66(1):9-16. PMID: 30039849
Aim: The article addresses selected determinants of the nursing shortage in Poland and other countries in the face of employee ageing. Background: Global demographic changes have led to a systematic...
2.
Immunology of Helicobacter pylori infection
Madalinski K, Dzierzanowska D, Januszewicz P
J Physiol Pharmacol . 2000 Mar; 50(5):807-15. PMID: 10695560
We have tried to answer several questions in this article, dealing with: ontogenesis of the immune response, presentation of H. pylori antigens to immune cells, systemic vs local immune response,...
3.
[Report of the commission for the prophylaxis of anterior segment eye infections newborns]
Czajkowski J, Gajewska E, Galczak W, Januszewicz P, Leibschang J, Prost M, et al.
Ginekol Pol . 1996 Aug; 67(8):421-2. PMID: 9139014
No abstract available.
4.
[Decreasing the risk of sudden infant death syndrome--SIDS. Recommendations of the Polish Occupational Group on sudden infant death syndromes and the Kracow Team of Medical Consultants in pediatrics and school medicine]
Januszewicz P, Kaczmarski M, Grygalewicz J, Rutkowska M, Helwich E, Czerwionka-Szaflarska M, et al.
Pediatr Pol . 1995 Jul; 70(7):615-6. PMID: 8649964
No abstract available.
5.
[Severe hypertension in children -- contemporary views on its etiopathogenesis and treatment]
Cichocka E, Wieteska-Klimczak A, Januszewicz P
Pediatr Pol . 1995 Feb; 70(2):153-9. PMID: 7603799
No abstract available.
6.
[Evaluation of the efficacy and safety of monotherapy for significant essential hypertension in adolescents with use of enalapril]
Cichocka E, WYSZYNSKA T, Januszewicz P, Kawalec W
Pediatr Pol . 1995 Feb; 70(2):145-51. PMID: 7603798
Clinical evaluation of hypotensive effectiveness and the cardiovascular and side effects of enalapril monotherapy of significant essential hypertension (SEH) in adolescents was performed. The studied group included 30 pts., aged...
7.
Effect of nifedipine on tubular handling of uric acid in transplanted kidney on cyclosporine A treatment
Zawadzki J, Grenda R, Januszewicz P
Nephron . 1995 Jan; 70(1):77-82. PMID: 7617121
Hyperuricemia resulting from tubular urate transport defects is a well-known nephrotoxic effect of cyclosporine A (CyA) on renal blood perfusion in organ recipients. The aim of this study was to...
8.
The renin-angiotensin-aldosterone system and vasopressin in early-stage liver cirrhosis after HBV infection in children
Winnicki C, Warnawin K, Januszewicz P, Socha J
J Pediatr Gastroenterol Nutr . 1994 Nov; 19(4):425-30. PMID: 7876998
We evaluated the dynamic response of renin, aldosterone, and vasopressin to intravenous water loading (20 ml 5% glucose/kg b.w.) in 12 children (aged 7-18 years) with postinflammatory liver cirrhosis after...
9.
[Disorders of uric acid tubular transport leading to hypouricemia]
Zawadzki J, Januszewicz P
Pol Arch Med Wewn . 1993 Feb; 89(2):142-9. PMID: 8502595
No abstract available.
10.
[Evaluation of the efficacy and tolerance of three antihypertensive agents used as single-drug therapy, nifedipine, prazosin and acebutolol in severe, idiopathic hypertension in adolescents]
Cichocka E, Januszewicz P, WYSZYNSKA T
Ann Pediatr (Paris) . 1993 Feb; 40(2):119-26. PMID: 8457132
The antihypertensive efficacy of single-drug therapy with nifedipine (N), prazosin (P), or acebutolol (A) and the influence of these agents on coronary risk factors including hypoglycemia, hyperuricemia, and hyperlipidemia, were...